Yoshizawa Seiichiro 吉澤成一郎

… Alternative Names

YOSHIZAWA Sei-ichiro 吉澤成一郎

Less

Researcher Number	70421063
Affiliation (Current)	2025: 東京医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2011 – 2016: 東京医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Laboratory medicine / Tumor diagnosis
Keywords	Principal Investigator リキッドバイオプシー / miRNA / エクソソーム / 造血幹細胞移植 / 移植片対宿主病 / 診断マーカー / miR-92a / 血清miRNA / 非ホジキンリンパ腫

Altered Exosomal miRNA expression of late onset acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Principal Investigator
- Principal Investigator
  
  Yoshizawa Seiichiro
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Laboratory medicine
- Research Institution
  Tokyo Medical University
Clinical impact of down-regulated plasma miR-92a levels in non-hodgkin's lymphomaPrincipal Investigator
- Principal Investigator
  
  YOSHIZAWA Sei-ichiro
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor diagnosis
- Research Institution
  Tokyo Medical University

All 2017 2016 2015 2014 2013 2012 2011

All Journal Article Presentation Book

[Book] 血液領域におけるmiRNA：Trends in Hematologcal Malignancies2013
- Author(s)
  吉澤成一郎、大屋敷一馬
- Publisher
  メディカルレビュー社
- Data Source
  KAKENHI-PROJECT-23701088
[Journal Article] BCR-ABL1-positive chronic myeloid leukemia emerging in a patient with secondary myelofibrosis harboring the JAK2-V617F mutation2017
- Author(s)
 Amemiya A, Ito Y, Ishibashi Y, Saito Y, Katagiri S, Suguro T, Asano M, Yoshizawa S, Akahane D, Tanaka Y, Fujimoto H, Okabe S, Gotoh M, Tauchi T, Ohyashiki K.
- Journal Title
 
 Rinsho Ketsueki
 
 Volume: 58 Issue: 4 Pages: 298-302
- DOI
 10.11406/rinketsu.58.298
- NAID
 130006882220
- ISSN
 0485-1439, 1882-0824
- Language
 Japanese
- Data Source
 KAKENHI-PROJECT-26860373
[Journal Article] Musculoskeletal pain after stopping tyrosine kinase inhibitor in patients with chronic myeloid leukemia: a questionnaire survey2016
- Author(s)
  Katagiri S, Tauchi T, Saito Y, Suguro T, Asano M, Yoshizawa S, Sakuta J, Akahane D, Tanaka Y, Furuya N, Ando K, Fujimoto H, Okabe S, Gotoh M, Ito Y, Ohyashiki K.
- Journal Title
  
  Rinsho Ketsueki
  
  Volume: 57 Issue: 7 Pages: 873-876
- DOI
  10.11406/rinketsu.57.873
- NAID
  130005254872
- ISSN
  0485-1439, 1882-0824
- Language
  Japanese
- Data Source
  KAKENHI-PROJECT-26860373
[Journal Article] Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib2015
- Author(s)
 Katagiri S, Tauchi T, Umezu T, Saito Y, Suguro T, Asano M, Yoshizawa S, Kitahara T, Akahane D, Tanaka Y, Fujimoto H, Okabe S, Gotoh M, Ito Y, Ohyashiki JH, Ohyashiki K
- Journal Title
 
 Rinsho Ketsueki
 
 Volume: 56 Issue: 2 Pages: 216-219
- DOI
 10.11406/rinketsu.56.216
- NAID
 130004920704
- ISSN
 0485-1439, 1882-0824
- Language
 Japanese
- Data Source
 KAKENHI-PROJECT-15K06841, KAKENHI-PROJECT-26860373
[Journal Article] Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.2014
- Author(s)
  Gotoh M, Yoshizawa S, Katagiri S, Suguro T, Asano M, Kitahara T, Akahane D, Okabe S, Gotoh A, Tauchi T, Ito Y, Ohyashiki K
- Journal Title
  
  Transplant Infectious Disease
  
  Volume: 16(3) Issue: 3 Pages: 440-449
- DOI
  10.1111/tid.12229
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26860373
[Journal Article] A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies2014
- Author(s)
  Gotoh M, Yoshizawa S, Katagiri S, Suguro T, Asano M, Kitahara T, Akahane D, Okabe S, Gotoh A, Tauchi T, Ito Y, Ohyashiki K
- Journal Title
  
  Bone Marrow Transplantation
  
  Volume: 49(7) Issue: 7 Pages: 955-960
- DOI
  10.1038/bmt.2014.66
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26860373
[Journal Article] Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders.2012
- Author(s)
  Yoshizawa S, Ohyashiki JH, Ohyashiki M, Umezu T, Suzuki K, Inagaki A, Iida S, Ohyashiki K.
- Journal Title
  
  Blood Cancer J.
  
  Volume: 2(1) Issue: 1 Pages: e53-e53
- DOI
  10.1038/bcj.2011.51
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23701087, KAKENHI-PROJECT-23701088
[Journal Article] Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders2012
- Author(s)
  Yoshizawa S, Ohyashiki JH, Ohyashiki M, Umezu T, Suzuki K, Inagaki A, Ohyashiki K
- Journal Title
  
  Blood Cancer J.
  
  Volume: 2(1)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23701088
[Journal Article] Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.2011
- Author(s)
  Ohyashiki K, Umezu T, Yoshizawa S, Ito Y, Ohyashiki M, Kawashima H, Tanaka M, Kuroda M, Ohyashiki JH
- Journal Title
  
  PLoS One.
  
  Volume: 6(2)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23701088
[Journal Article] Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma2011
- Author(s)
  Ohyashiki K, Umezu T, Yoshizawa S, Ito Y, Ohyashiki M, Kawashima H, Tanaka M, Kuroda M, Ohyashiki JH
- Journal Title
  
  PLoS One
  
  Volume: 6(2)
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Anti-angiogenic effect of normal bone marrow stromal cell-derived exosomes rejuvenated by miR-340.2016
- Author(s)
  Umezu T, Imanishi S, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki J
- Organizer
  The 78th Annual Meeting of Japanese Society of Hematology
- Place of Presentation
  Yokohama
- Year and Date
  2016-10-13
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] Mutation analysis of bone marrow stromal cells derived from AML and MDS.2016
- Author(s)
  Azuma K, Umezu T, Imanishi S, Asano M, Yoshizawa S, Katagiri S, Ohyashiki K, Ohyashiki JH
- Organizer
  The 78th Annual Meeting of Japanese Society of Hematology
- Place of Presentation
  Yokohama
- Year and Date
  2016-10-13
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] 骨髄間質細胞が放出するエクソソーム内加齢関連miRNAの同定と機能解析2016
- Author(s)
  関野知聖、梅津知宏、吉澤成一郎、大屋敷一馬、大屋敷純子
- Organizer
  第178回東京医科大学医学会総会
- Place of Presentation
  東京
- Year and Date
  2016-11-05
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] Exosomal miRNA signature of late onset acute graft-versus-host disease in allogenic hematopoietic stem cell transplantation.2015
- Author(s)
  Yoshizawa S, Umezu T, Saitoh Y, Gotoh M, Akahane D, Kobayashi C, Ohyashiki JH, Ohyashiki K
- Organizer
  第77回日本血液学会学術集会学術集会
- Place of Presentation
  金沢
- Year and Date
  2015-10-16
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] Bone marrow mesenchymal stromal cells from healthy donors secrete exosomes that inhibit in vivo tumor growth and angiogenesis in multiple myeloma.2015
- Author(s)
  Umezu T, Imanishi S, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki JH
- Organizer
  20th Congress of European Hematology Association (EHA)
- Place of Presentation
  Vienna, Austria
- Year and Date
  2015-06-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] Age-related alterations in exosomal miRNAs derived from bone marrow mesenchymal stromal cells.2015
- Author(s)
  Umezu T, Imanishi S, Yoshizawa S, Saitoh Y, Yamamoto Y, Ohyashiki K, Ohyashiki JH
- Organizer
  6th JSH International Symposium 2015
- Place of Presentation
  軽井沢
- Year and Date
  2015-05-22
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] Exosomal miRNA signature of bone marrow mesenchymal stromal cells derived from MDS patients.2015
- Author(s)
  Saitoh Y, Imanishi S, Umezu T, Yoshizawa S, Asano M, Fujimoto H, Akahane D, Yamamoto Y, Kobayashi C, Ohyashiki JH, Ohyashiki K
- Organizer
  第77回日本血液学会学術集会学術集会
- Place of Presentation
  金沢
- Year and Date
  2015-10-16
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] Distinct exosomal miRNA expression of late onset graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.2015
- Author(s)
  Yoshizawa S, Umezu T, Saitoh Y, Gotoh M, Akahane D, Kobayashi C, Ohyashiki JH, Ohyashiki K
- Organizer
  20th Congress of European Hematology Association (EHA)
- Place of Presentation
  Vienna, Austria
- Year and Date
  2015-06-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] Exosome-based therapeutic approach using exosomal miRNAs derived from bone marrow mesenchymal stromal cells.2015
- Author(s)
  Umezu T, Imanishi S, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki JH
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] 同種造血幹細胞移植のGVHDに特異的なexosomal miRNAの解析2014
- Author(s)
  吉澤成一郎
- Organizer
  第174回東京医科大学医学会総会
- Place of Presentation
  東京（新宿）
- Year and Date
  2014-11-01
- Data Source
  KAKENHI-PROJECT-26860373
[Presentation] Lower plasma miR-92a levels in newly diagnosed symptomatic multiple myeloma patients with poor-risk cytogenetics2013
- Author(s)
  Yoshizawa S
- Organizer
  14th International Myeloma Workshop
- Place of Presentation
  京都
- Year and Date
  2013-04-03
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Lower plasma miR-92a levels predict shorter progression-free survival in newly diagnosed symptomatic multiple myeloma patients2013
- Author(s)
  Yoshizawa S
- Organizer
  55th Annual meeting of ASH
- Place of Presentation
  New Orieans
- Year and Date
  2013-12-07
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Feasibility of plasma miR-92a as a prognostic marker in newly diagnosed multiple myeloma patients2013
- Author(s)
  Yoshizawa S
- Organizer
  日本血液学会
- Place of Presentation
  札幌
- Year and Date
  2013-10-11
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Lower Plasma miR-92a Levels in Newly Diagnosed Symptomatic Multiple Myeloma patients with Poor-Risk Cytogenetics.2013
- Author(s)
  Yoshizawa S
- Organizer
  14th International Myeloma Workshop
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Feasibility of plasma MiR-92a as a prognostic marker in newly diagnosed multiple myeloma patients.2013
- Author(s)
  Yoshizawa S
- Organizer
  日本血液学会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Lower plasma miR-92a levels predict shorter progression-free survival in newly diagnosed symptomatic multiple myeloma patients.2013
- Author(s)
  Yoshizawa S
- Organizer
  55th Annual Meeting of ASH
- Place of Presentation
  New Orleans
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] 多発性骨髄腫における血清miR-92aの臨床的意義2011
- Author(s)
  吉澤成一郎、梅津知宏、藤本博昭、後藤守孝、木村之彦、大屋敷一馬、大屋敷純子
- Organizer
  第73回日本血液学会学術集会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-16
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] 多発性骨髄腫における血清miR-92a低下は末梢T細胞由来miR-92aを反映する2011
- Author(s)
  吉澤成一郎、大屋敷一馬、大屋敷倫代、藤本博昭、後藤守孝、後藤明彦、北原俊彦、岩渕多光子、梅津知宏、小林千晶、廣田綾子、大屋敷純子
- Organizer
  第36回日本骨髄腫研究会総会
- Place of Presentation
  東京
- Year and Date
  2011-11-12
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Plasma Mir-92a Levels in Multiple Myeloma Correlate with T-cell-Derived Mir-92a and Restored in Bortezomib Responder2011
- Author(s)
  Sei-ichiro Yoshizawa, Junko H. Ohyashiki, Michiyo Ohyashiki, Tomohiro Umezu, Kenshi Suzuki, Atsushi Inagaki, Shinsuke Iida, and Kazuma Ohyashiki
- Organizer
  53rd ASH annual meeting and Exposition
- Place of Presentation
  San Diego、CA
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Clinical Impact Of Low Plasma miR-92a Levels in Monoclonal ganmmopathies2011
- Author(s)
  Sei-ichiro Yoshizawa, Junko H. Ohyashiki, Tomohiro Umezu, Kenshi Suzuki, Atsushi Inagaki, Shinsuke Iida, and Kazuma Ohyashiki
- Organizer
  The 13th International Myeloma Workshop
- Place of Presentation
  Paris
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Plasma miR=92a levels in multiple myeloma correlate with T cell derived miR-92a and restored in bortezomib responder2011
- Author(s)
  Yoshizawa S, Ohyashiki JH, Ohyashiki M, Umezu T, Suzuki K, Inagaki A, Iida S, Ohyashiki K
- Organizer
  53rd ASH annual meeting and exposition
- Place of Presentation
  San Diego
- Year and Date
  2011-12-11
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] Clinical impact of low plasma miR-92a levels in monoclonal gammopathies2011
- Author(s)
  Yoshizawa S, Ohyashiki JH, Umezu T, Suzuki K, Inagaki A, Iida S, Ohyashiki K
- Organizer
  The 13th International Myeloma Workshop
- Place of Presentation
  Paris
- Year and Date
  2011-05-04
- Data Source
  KAKENHI-PROJECT-23701088
[Presentation] 形質細胞腫瘍とマイクロRNA2011
- Author(s)
  吉澤成一郎、梅津知宏、藤本博昭、後藤守孝、木村之彦、大屋敷一馬、大屋敷純子、飯田真介、鈴木憲史
- Organizer
  第11回血液疾患フォーラム
- Place of Presentation
  東京
- Year and Date
  2011-10-22
- Data Source
  KAKENHI-PROJECT-23701088

1. UMEZU Tomohiro (40385547)

# of Collaborated Projects: 1 results

# of Collaborated Products: 10 results

Yoshizawa Seiichiro 吉澤 成一郎

YOSHIZAWA Sei-ichiro 吉澤 成一郎

Research Projects

Research Products

Co-Researchers

Altered Exosomal miRNA expression of late onset acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clinical impact of down-regulated plasma miR-92a levels in non-hodgkin's lymphomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 血液領域におけるmiRNA：Trends in Hematologcal Malignancies2013

Author(s)

Publisher

Data Source

[Journal Article] <i>BCR-ABL1</i>-positive chronic myeloid leukemia emerging in a patient with secondary myelofibrosis harboring the <i>JAK2</i>-V617F mutation2017

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

[Journal Article] Musculoskeletal pain after stopping tyrosine kinase inhibitor in patients with chronic myeloid leukemia: a questionnaire survey2016

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

[Journal Article] Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with <i>BIM</i> deletion polymorphism relapsed after stop imatinib2015

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

[Journal Article] Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders.2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders2012

Author(s)

Journal Title

Data Source

[Journal Article] Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.2011

Author(s)

Journal Title

Data Source

[Journal Article] Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma2011

Author(s)

Journal Title

Data Source

[Presentation] Anti-angiogenic effect of normal bone marrow stromal cell-derived exosomes rejuvenated by miR-340.2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Mutation analysis of bone marrow stromal cells derived from AML and MDS.2016

Author(s)

Yoshizawa Seiichiro 吉澤成一郎

YOSHIZAWA Sei-ichiro 吉澤成一郎